Activation-induced T-cell death and immune dysfunction after implantation of left-ventricular assist device.

Ankersmit, H J; Tugulea, S; Spanier, T; Weinberg, A D; Artrip, J H; Burke, E M; Flannery, M; Mancini, D; Rose, E A; Edwards, N M; Oz, M C; Itescu, S

Ankersmit, H J; Tugulea, S; Spanier, T; Weinberg, A D; Artrip, J H; Burke, E M; Flannery, M; Mancini, D; Rose, E A; Edwards, N M; Oz, M C; Itescu, S.

Affiliation

Ankersmit HJ; Department of Surgery, College of Physicians and Surgeons of Columbia University, New York, NY 10032, USA.

Lancet ; 354(9178): 550-5, 1999 Aug 14.

Article in En | MEDLINE | ID: mdl-10470699

Subject(s)

Candidiasis/etiology; Heart Failure/immunology; Heart Failure/surgery; Heart-Assist Devices/adverse effects; T-Lymphocytes/immunology; Adolescent; Adult; Aged; Apoptosis; Candidiasis/epidemiology; Cell Death; Female; Flow Cytometry; Heart Failure/complications; Heart-Assist Devices/microbiology; Humans; Lymphocyte Activation; Male; Middle Aged; Risk Factors; T-Lymphocytes/cytology

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Candidiasis / T-Lymphocytes / Heart-Assist Devices / Heart Failure Type of study: Clinical_trials / Etiology_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Lancet Year: 1999 Type: Article Affiliation country: United States

Search on Google

XML

PubMed Links